Cite
HARVARD Citation
Ikeda, S. et al. (2022). Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents. Psychological medicine. 52 (13), pp. 2822-2834. [Online].